Equity Overview
Price & Market Data
Price: $2.69
Daily Change: -$0.21 / 7.81%
Daily Range: $2.52 - $2.80
Market Cap: $148,144,320
Daily Volume: 81,285
Performance Metrics
1 Week: 7.29%
1 Month: 6.00%
3 Months: 3.11%
6 Months: 58.68%
1 Year: 208.1%
YTD: -6.03%
Company Details
Employees: 62
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.